The world's first mRNA vaccine against a deadly disease

Published Date: 15 Mar 2023

A world first: A research team from Tel Aviv University and the Israel Institute of Biology has developed an anti-mRNA drug that is 100% effective against a single type of virus.

Read Full News

Latest News

Systemic Onychomycosis Rxs: Hepatoxicity Risks Compared

Terbinafine shows lower risk for hepatotoxicity than other systemic antifungal treatments in patients with onychomycosis and chronic liver disease.

Replimune's Drug for Advanced Skin Cancer Fails to Win FDA Nod Again

The U.S. Food and Drug Administration on Friday declined to approve Replimune's drug ⁠for advanced skin cancer, citing insufficient data from studies, sending its shares...

Most US Infants Have an Enteric Viral Infection by Age 2

Norovirus GII and sapovirus were the most common pathogens and would be targets for vaccines.

Conference MDAngle: AAN 2026 Myasthenia Gravis

Insights from AAN 2026, including anticipated presentations, key takeaways, and how emerging research in myasthenia gravis may affect patient care.

Neuroimmunome Predicts Viral Hepatitis Severity

A neuroimmune gene signature detectable in blood and liver predicts viral hepatitis severity, suggesting nervous-immune crosstalk drives disease progression and informs monitoring.

Potato Allergy in Children: New Data

Potato allergies tend to appear in infancy, often with skin symptoms, and may be triggered by the vegetable when it is cooked or raw, according to a Turkish study.

Todays Updates

Is the Viral Plastic Diet Linked to Eating Disorder Risk?

A viral plastic diet trend raises concerns for choking, metabolic disruption, and increased risk for eating disorders among youth.

Exercise Intensity Over Volume Linked to Lower Disease Risks

Higher intensity of physical activity, regardless of total volume, is linked to significantly lower risks for many cardiovascular and other chronic diseases and death.

Todays Updates

Is the Viral Plastic Diet Linked to Eating Disorder Risk?

A viral plastic diet trend raises concerns for choking, metabolic disruption, and increased risk for eating disorders among youth.

Exercise Intensity Over Volume Linked to Lower Disease Risks

Higher intensity of physical activity, regardless of total volume, is linked to significantly lower risks for many cardiovascular and other chronic diseases and death.

Latest News

Terbinafine shows lower risk for hepatotoxicity than other systemic antifungal treatments in patients with onychomycosis and chronic liver disease.

The U.S. Food and Drug Administration on Friday declined to approve Replimune's drug ⁠for advanced skin cancer, citing insufficient data from studies, sending its shares...

Norovirus GII and sapovirus were the most common pathogens and would be targets for vaccines.

Insights from AAN 2026, including anticipated presentations, key takeaways, and how emerging research in myasthenia gravis may affect patient care.

A neuroimmune gene signature detectable in blood and liver predicts viral hepatitis severity, suggesting nervous-immune crosstalk drives disease progression and informs monitoring.

Potato allergies tend to appear in infancy, often with skin symptoms, and may be triggered by the vegetable when it is cooked or raw, according to a Turkish study.

News All Time

Early Oral Antibiotics: A Safe Shift in Bone Infections

Early switching from intravenous to oral treatment does not compromise treatment success in children with bone and joint infections and may reduce the risk for complications.

AD Not Linked to Poor Academic Performance in Adolescents

Atopic dermatitis does not significantly impair academic performance, a study finds.

High-Flow Oxygen Slightly Reduces Intubation, Not Mortality

High-flow nasal oxygen appears to reduce intubation incidence but does not reduce mortality in ICU patients with acute hypoxemic respiratory failure.

Sunscreen Use Has Doubled Among Black Individuals

The rate at which individuals with darker skin tones take steps to protect themselves from the sun has doubled in 20 years, but there is a great distance to go.

Dermatologist’s Guide to Patients With Personality Disorders

Reassurance, routine, and respect are key to navigating difficult encounters.

Biomarkers Track AD Severity in Children

Serum thymus and activation-regulated chemokine and squamous cell carcinoma antigen 2 are superior to total IgE or eosinophils in assessing atopic dermatitis severity, a retrospective study finds.

Treating IgG4-RD: How Far Will B-Cell Drugs Take the Field?

Post hoc analyses of pivotal MITIGATE trial show broad efficacy across patient subgroups with differing organ involvement and clinical characteristics.

Growth in Sector, Private Equity Fuel Hospitalist Lawsuits

Malpractice claims against hospitalists highest of any specialty.

Predicting Early Death in Immunocompromised Status With ARF

In immunocompromised patients with acute hypoxemic respiratory failure, frailty and longer hospital-to-ICU time may raise 30-day mortality, whereas high-flow nasal oxygen is protective.

Autoimmune Disease in Parent Tied to Allergy Risk in Child

Having a parent with an autoimmune disease may be associated with an increased risk for allergic diseases, a meta-analysis shows.

GLP-1 Drugs Under Scrutiny: How Real Are the Risks?

Gastrointestinal adverse effects remain a key barrier to continued use of these agents, with slower dose titration emerging as a strategy to improve tolerability and adherence.

Early Warning Scores Fairly Accurate in Older Adults in ED

Early warning scores fairly predict 24-h deterioration in adults aged 80 years or older in the emergency department, with the Rapid Emergency Medicine Score more consistent and improving with age.

Mediterranean Diet Linked to Lower Adult-Onset Asthma Risk

Clinicians can reasonably include Mediterranean-style eating in respiratory prevention counseling — alongside smoking cessation, exercise, weight control, and exposure reduction.

Abrocitinib Effective for Hand Eczema in Phase 2 Study

In the phase 2 trial, efficacy was also seen in patients with non-atopic chronic hand eczema treated with the oral JAK inhibitor.

Ciprofloxacin for Transplant Prophylaxis: Time to Rethink?

In allogeneic haematopoietic cell transplant recipients, ciprofloxacin prophylaxis may reduce bloodstream infections but is tied to higher rates of antimicrobial resistance and antibiotic use.

Docs, Lawsuit Challenge Medicare WISeR Prior Auth Experiment

Doctors in multiple states report unpaid claims and care delays under the new federal program, as a lawsuit seeks answers about AI algorithms and data security.

Recommended News For You

'Chemo brain' cognitive issues linked to poor lymphatic-system drainage

Risk-Benefit Analysis of CAR-T Therapies for Myeloma is Muddy by Early Death Risk.

the contribution of cortactin to the development of cancer.

Molecular profiling of renal medullary carcinoma identifies TROP2 as a promising therapeutic target

It Is Not Just the Royals Who Go Through Cancer.

TULSA Is Effective in Long-Term Prostate Cancer Control.

Cancer patients with HIV have demonstrated safety with immune checkpoint inhibitors.

Recommended Articles For You

Lymphomatoid Papulosis: What You Need to Know 

Unleashing the Oncolytic Arsenal: Talimogene Laherparepvec Monotherapy – A Targeted Cancer Immunotherapy Treatment 

Cancer Care Advances: Metformin, Digital Tools, and Artificial Renal Support 

The Link Between Being Overweight and Cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Report provides global picture of wide inequalities in care for women's cancers

2.

A hint regarding aspirin, the connection to colon cancer, the approval of the new Lutathera, artificial intelligence, and electronic records.

3.

Kate Middleton and Remission: Oncologists Weigh In

4.

In a randomized trial, the kinder, gentler regimen for classical Hodgkin wins out.

5.

Mental health risk persists years after cancer diagnosis

1.

The Basics of Langerhans Cell Histiocytosis: Understanding a Rare Disease 

2.

Esophageal Cancer Survival Rates and Outcomes: Evidence-Based Insights from Oncology Studies

3.

A Revolutionary Guide to Calculating Absolute Neutrophil Counts

4.

Studying Lactic Acid in Pediatric Tumor Microenvironments: Experimental Approaches Explored

5.

Harnessing Artificial Intelligence in Oncology: Innovations in Diagnosis, Treatment, and Patient Care

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V

2.

From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD

3.

The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion

4.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

5.

Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot